Embracing AI in Clinical Trials: An Oncology CRO’s Insight

Read article

Cancer Vaccines – Promising Research Gets Closer to Reality

Vaccines are at the top of everyone’s mind…
Read Article

Selecting a CRO During the COVID-19 Pandemic

In 2014, we wrote a popular post about…
Read Article

Tips for Bringing Your First Oncology Drug into the Clinic in the United States

While cancer is a global health challenge, the…
Read Article

FDA Guidance on Conduct of Clinical Trials During COVID-19

These are challenging times, as the world grapples…
Read Article

Preparing for Your Phase I Oncology Study

The phase 1 study is the gateway between…
Read Article

Managing the Side Effects in a CAR T-cell Therapy Study

CAR T-cell therapy, together with checkpoint inhibition, has…
Read Article

Meet Medelis at the ASH 2019 Annual Meeting

It’s almost December, and that means it’s time…
Read Article

Join Medelis at BIO-Europe 2019

BIO-Europe is Europe's largest life science partnering conference…
Read Article

Common Causes of Delays in Immuno-Oncology Studies

It’s common for “standard” oncology studies to encounter…
Read Article